Lysyl oxidase: A lung adenocarcinoma biomarker of invasion and survival

Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancers

(2010) A. Saadi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Invasive Size is an Independent Predictor of Survival in Pulmonary Adenocarcinoma

(2009) Alain C. Borczuk et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Hypoxia-Induced Lysyl Oxidase Is a Critical Mediator of Bone Marrow Cell Recruitment to Form the Premetastatic Niche

(2009) Janine T. Erler et al.   CANCER CELL

Bioreductively Activated Lysyl Oxidase Inhibitors against Hypoxic Tumours

(2009) Carlotta Granchi et al.   ChemMedChem

The Lysyl Oxidase Inhibitor, β-Aminopropionitrile, Diminishes the Metastatic Colonization Potential of Circulating Breast Cancer Cells

(2009) Alla Bondareva et al.   PLoS One

Stromal gene expression predicts clinical outcome in breast cancer

(2008) Greg Finak et al.   NATURE MEDICINE